Necrotizing fasciitis (NF) is a rapidly progressive, life-threatening infection of the soft tissues with mortality rates of 10–30% and misdiagnosis rates of 41–96% at initial presentation. [1-2] The cornerstone of management is early surgical debridement — ideally within 6 hours of presentation — combined with broad-spectrum IV antibiotics and ICU-level supportive care. [1]
The following figure illustrates the two pathogenic mechanisms — portal-of-entry and cryptogenic — by which necrotizing soft-tissue infections evolve through progressive tissue destruction:
1. History
- Pain characterization: Crescendo pain or pain out of proportion to exam findings is the single most important early clue, particularly in cryptogenic group A streptococcal (GAS) infections [2-3]
- Portal of entry: Minor abrasion, insect bite, injection site, boil, recent surgery, childbirth, or trauma; a small minority have no visible skin lesion [4]
- Timing/progression: Rapid onset (hours) of worsening pain, swelling, erythema that spreads despite antibiotics
- Associated symptoms: Fever, malaise, disorientation, lethargy, nausea/vomiting
- Important negatives: Pain may be absent or attenuated in patients on NSAIDs/analgesics, those with diabetic neuropathy, altered mental status, or postoperative patients where pain is attributed to the procedure [3]
- Ask about recent saltwater/shellfish exposure (Vibrio vulnificus), freshwater exposure (Aeromonas), and IV drug use [2][5]
2. Alarm Features
- Pain out of proportion to visible skin findings [2-3]
- Rapid progression of erythema/induration despite appropriate antibiotics [2][4]
- Systemic toxicity: hypotension, tachycardia, altered mental status, high fever [4]
- Skin changes: violaceous/cyanotic discoloration, hemorrhagic bullae, skin necrosis, crepitus [1-2]
- Wooden-hard induration of subcutaneous tissues (vs. soft/yielding in cellulitis) [4]
- Hypoesthesia over the affected area (cutaneous nerve destruction) [2]
- Dishwater-gray wound drainage [1]
- Gas in soft tissues on exam or imaging [4]
Pearl: Classic "hard signs" (bullae, necrosis, crepitus) are present in <50% of cases — their absence never excludes the diagnosis. [1-2]
3. Medications
Empiric Antibiotics (IDSA Guidelines): [4]
- Vancomycin (or linezolid/daptomycin for MRSA coverage) PLUS one of:
- Piperacillin-tazobactam 4.5 g IV q6-8h
- Carbapenem (meropenem 1-2 g IV q8h, imipenem-cilastatin, or ertapenem)
- Ceftriaxone + metronidazole
- Fluoroquinolone + metronidazole
- Clindamycin 600-900 mg IV q6-8h — add in suspected toxic shock syndrome to suppress exotoxin production [1-2]
- For confirmed GAS monomicrobial NF: penicillin + clindamycin [4]
- Consider empiric antifungals in immunocompromised patients [1]
Medication Cautions
- NSAIDs may mask crescendo pain and delay diagnosis; some data suggest they may worsen NF progression [3]
- Aminoglycosides should be reserved for septic shock and require renal dose adjustment [2]
Duration: Continue antibiotics until no further debridement is needed, clinical improvement achieved, and afebrile for 48–72 hours [1-2][4]
4. Diet
- NPO if surgical debridement anticipated
- Aggressive IV fluid resuscitation — these wounds discharge copious tissue fluid [4]
- Nutritional optimization is critical during recovery (high protein, caloric supplementation) given massive tissue loss and catabolic state
- Long-term: optimize glycemic control in diabetic patients
5. Review of Systems
- Constitutional: Fever, chills, rigors, malaise, confusion, lethargy
- Skin: Rapidly spreading redness, blistering, color changes, numbness over affected area
- MSK: Severe pain, inability to use affected limb
- GI/GU: Perineal pain, scrotal swelling (Fournier gangrene), recent abdominal/pelvic surgery
- Vascular: Symptoms of peripheral arterial disease, claudication
- Psych: IV drug use history, alcohol use
6. Collateral History and Family History
- Collateral: Witnesses to timeline of symptom progression (critical for establishing rapidity); medication list including recent antibiotics, NSAIDs, immunosuppressants
- Social context: IV drug use (2–80% of cases), chronic alcohol use (6–30%), homelessness, recent incarceration [1]
- Exposures: Recent saltwater/raw seafood (Vibrio), freshwater, soil contamination, animal bites
- Family history is generally not contributory, though hereditary immunodeficiency states may increase susceptibility
7. Risk Factors
- Diabetes mellitus (22–59% of cases) [1][6]
- Obesity (17–39%) [1]
- Cardiovascular disease (9–45%) [1]
- Peripheral arterial disease (3–19%) [1]
- IV drug use (2–80%) [1]
- Chronic alcohol use (6–30%) [1]
- Immunosuppression (4–30%): organ transplant, HIV, chemotherapy, chronic steroids [1]
- Chronic liver disease (1–4%) [1]
- Recent surgery, trauma, or childbirth [3]
- Up to 25% of patients have no underlying comorbidities [1]
Mortality predictors: age >65, female sex, peripheral vascular disease, renal impairment, MAP <60 mmHg, bacteremia, hyperlactatemia [2][7]
8. Differential Diagnosis
- Severe cellulitis/erysipelas — most common mimic; subcutaneous tissue is soft and yielding (vs. wooden-hard in NF) [4]
- Abscess — focal fluctuance, rim-enhancing collection on imaging
- Gas gangrene (clostridial myonecrosis) — rapid onset, crepitus, bronze discoloration, extreme toxicity
- Pyomyositis — deep muscle infection, often subacute; MRI shows intramuscular abscess
- Deep vein thrombosis — unilateral limb swelling/pain without skin changes
- Calciphylaxis — in ESRD patients; painful skin necrosis but without infectious signs
- Toxic epidermal necrolysis — widespread skin sloughing, mucosal involvement, drug exposure
- Acute compartment syndrome — pain with passive stretch, tense compartment, no systemic infection
- Warfarin-induced skin necrosis — early anticoagulation, protein C/S deficiency
9. Past Medical History
- Prior episodes of NF or severe soft tissue infections
- Diabetes (type and control, HbA1c, neuropathy status)
- Peripheral vascular disease, prior amputations
- Immunosuppressive conditions or medications
- Chronic kidney or liver disease
- Recent surgeries, procedures, or hospitalizations
- Varicella or other recent viral infections (in pediatric cases)
10. Physical Exam
Vital Signs
- Tachycardia, hypotension (21% sensitivity, 98% specificity for NSTI) [8]
- Fever present in only 40–60% [2-3]
Focused Exam
- Erythema (72%), edema (75%), severe tenderness (68%) [3]
- Wooden-hard induration of subcutaneous tissue — a distinguishing feature from cellulitis [4]
- Skin necrosis, hemorrhagic bullae (38%) — highly specific (96%) but insensitive (25%) [3][8]
- Crepitus — suggests gas-forming organisms; highly specific
- Hypoesthesia/anesthesia over affected area — indicates cutaneous nerve destruction [2]
- Erythema extending beyond marked borders on serial exam [1]
- Finger test/probe test: If open wound present, blunt instrument dissects easily along fascial planes well beyond wound margins [4]
- Assess for perineal involvement (Fournier gangrene)
Pearl: Serial exams every 4–6 hours are essential when diagnosis is uncertain. [1]
11. Lab Studies
Recommended Labs
- CBC with differential (WBC >15,400/μL suggestive) [1][3]
- BMP: sodium (<135 mEq/L suggestive), creatinine, glucose, BUN (>15 mg/dL) [1]
- CRP (>150 mg/L scores 4 points on LRINEC) [3]
- Lactate — elevated lactate is an independent predictor of amputation and mortality; lactate ≥2.0 mmol/L had 100% sensitivity in one series [2][9]
- Procalcitonin — elevated on admission associated with progression to septic shock [2]
- CK/AST — elevated levels suggest deep infection involving muscle or fascia [3]
- Blood cultures (×2 sets before antibiotics)
- Coagulation studies (PT/INR, fibrinogen — assess for DIC)
- Type and screen
- Albumin (hypoalbuminemia associated with worse outcomes) [6]
LRINEC Score (6 variables: CRP, WBC, hemoglobin, sodium, creatinine, glucose): [10]
- Score ≥6: PPV 57–92%, sensitivity 49–75% [1][8]
- Score ≥8: specificity 95%, but sensitivity only 41% [1]
- A low LRINEC score does NOT rule out NF — clinical suspicion takes precedence [1-2]
NECROSIS Score — 3 independent predictors: SBP ≤120 mmHg + violaceous skin + WBC >15,000/μL → all 3 present = 100% specificity and PPV [1]
12. Imaging
- Should NEVER delay surgical exploration[1-2]
Plain Radiographs
- First-line; may show soft tissue gas (pathognomonic in absence of trauma) [9]
- Sensitivity only 49%, specificity 94% [8]
CT Scan (with IV contrast)
- Best for abdominoperineal or cervicofacial NF to identify portal of entry and guide surgery [2]
- Sensitivity 88.5%, specificity 93.3% [8]
- Findings: gas in soft tissues, fluid collections along fascial planes, asymmetric fascial thickening, lack of fascial enhancement (most specific finding) [2-3]
MRI
- Most sensitive for limb NF in stable, equivocal cases [2]
- Thickened fascia (>3 mm) with hyperintensity on T2-weighted/fat-suppressed sequences [2-3]
- Sensitive but not entirely specific — may overcall
When imaging is unnecessary: Unstable patients or those with high clinical suspicion should go directly to the OR [1-2]
13. Special Tests
Scoring Systems
The LRINEC Score can be calculated using the tool below
Point-of-Care
- Bedside ultrasound: may show fascial thickening, fluid tracking along fascial planes, subcutaneous air
- Finger test (bedside incision): lack of bleeding, dishwater-gray fluid, lack of tissue resistance to blunt dissection = positive [12]
Intraoperative Findings (Gold Standard): [1][12]
- Gray, necrotic fascia
- Dishwater fluid (not frank pus)
- Obliteration of tissue planes
- Thrombosed vessels
- Lack of bleeding
- Positive finger test (no resistance to dissection)
- Noncontracting muscle
14. ECG
- Obtain ECG as part of preoperative assessment and sepsis workup
- Look for tachycardia, signs of hyperkalemia (peaked T waves, widened QRS) in setting of renal failure/rhabdomyolysis
- Assess for myocardial ischemia in the setting of septic shock
- No NF-specific ECG findings, but critical for perioperative risk stratification
15. Assessment
Clinical Summary: NF is a surgical emergency with a misdiagnosis rate of 41–96%. [1] It presents on a spectrum from insidious cellulitis-like onset to fulminant septic shock. The diagnosis is ultimately surgical — confirmed by intraoperative findings of fascial necrosis. [1][12]
Severity Stratification
- Mild/early: Pain out of proportion, erythema, edema without systemic toxicity
- Moderate: Spreading erythema, systemic toxicity, lab derangements
- Severe/fulminant: Septic shock, multiorgan failure, extensive skin necrosis
Typical vs. Atypical
- Typical: Extremity involvement, identifiable portal of entry, progressive pain/erythema
- Atypical: Cryptogenic (no portal of entry), deep-seated pain without skin changes, perineal/cervicofacial location, immunocompromised host with blunted inflammatory response
Complications: Septic shock, DIC, multiorgan failure, limb loss (amputation rate ~17%), toxic shock syndrome, massive tissue defects requiring reconstruction [6-7]
16. Treatment Plan
Initial Stabilization
- ABCs, large-bore IV access, aggressive crystalloid resuscitation
- Vasopressors if refractory hypotension (norepinephrine first-line)
- Blood cultures → immediate broad-spectrum IV antibiotics (see Medications above)
Surgical Management: [1][4]
- Emergent surgical debridement — aim for OR within 6 hours of presentation
- Remove all necrotic tissue until only healthy, bleeding tissue remains
- Obtain deep tissue cultures (aerobic, anaerobic, fungal) and Gram stain intraoperatively
- Re-exploration every 12–24 hours until no further debridement needed [1]
- Average patient requires ~3 debridements [12]
- Accept a ~20% negative exploration rate — better to explore and be wrong than to miss NF [1]
Adjunctive
- ICU admission for hemodynamic monitoring, organ support
- IVIG may be considered in streptococcal toxic shock syndrome (limited evidence) [12]
- Hyperbaric oxygen: not routinely recommended; should never delay surgery [1]
- Wound management: negative-pressure wound therapy after source control
- Reconstructive surgery (skin grafting, flaps) once infection controlled
Do NOT transfer before debridement if surgical capability exists — transfer delays are associated with higher mortality. [1]
17. Disposition
Admission Criteria (all confirmed or suspected NF)
- ICU admission for hemodynamic instability, sepsis, multiorgan dysfunction, or need for serial debridements
- Surgical floor if stable post-debridement with improving trajectory
Observation Indications
Specialist Consultation Triggers
- Immediate surgical consultation for any suspected NF — this is non-negotiable [4]
- Critical care/intensivist for sepsis management
- Infectious disease for antibiotic optimization
- Plastic surgery/reconstructive surgery for wound coverage planning
Transfer Considerations: Transfer to a center with surgical and ICU capability only if local resources are unavailable — but do not delay debridement for transfer [1]
18. Follow Up / Return Precautions
Inpatient Follow-Up
- Daily wound assessment and re-debridement as needed
- Trend WBC, CRP, lactate, procalcitonin for treatment response
- Narrow antibiotics based on deep tissue culture results
- Nutritional support, physical/occupational therapy early
- Psychological support — NF survivors have high rates of PTSD, depression, and body image disturbance
Post-Discharge
- Wound care follow-up within 1 week
- Surgical follow-up for wound reconstruction planning
- Monitor for wound complications (secondary infection, dehiscence)
- Diabetes management optimization if applicable
Return Precautions (for patients discharged after cellulitis observation who did not undergo surgery):
- Return immediately for: worsening pain, spreading redness beyond marked borders, skin color changes (purple/black), blistering, fever, confusion, or feeling significantly worse
- Expected recovery: cellulitis should improve within 48–72 hours of appropriate antibiotics; failure to improve warrants re-evaluation for NF
References
1. Necrotizing Soft Tissue Infections: A Review. — McDermott J, Kao LS, Keeley JA, et al. JAMA Surgery. 2024.
2. Necrotising Soft-Tissue Infections. — Hua C, Urbina T, Bosc R, et al. The Lancet. Infectious Diseases. 2023.
3. Necrotizing Soft-Tissue Infections. — Stevens DL, Bryant AE. The New England Journal of Medicine. 2017.
4. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
5. Initial Skin Necrosis Presentation at Emergency Room Was Associated With Fulminant Clinical Course and Mortality in Patients With Vibrio Necrotizing Fasciitis. — Hsiao CY, Huang TY, Teng LY, et al. Scientific Reports. 2023.
6. Epidemiology and Prognostic Factors of Necrotizing Fasciitis in Resource-Limited Regions Based on 119 Cases. — Chen Y, Huang Y, Shou J, et al. Scientific Reports. 2025.
7. Predictors of Clinical Outcomes in Necrotizing Fasciitis: A Ten Year Study. — Jegathesan T, Ho SWL, Tham SYY, Ang MLT. International Orthopaedics. 2025.
8. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis. — Fernando SM, Tran A, Cheng W, et al. Annals of Surgery. 2019.
9. Cellulitis: A Review. — Raff AB, Kroshinsky D. The Journal of the American Medical Association. 2016.
10. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) Score: A Tool for Distinguishing Necrotizing Fasciitis From Other Soft Tissue Infections. — Wong CH, Khin LW, Heng KS, Tan KC, Low CO. Critical Care Medicine. 2004.
11. Three Ds for Diagnosing Necrotizing Fasciitis by Front-Line Clinicians. — Haykal S, Hadzimustafic N, Ghazarian D, Musgrave M. Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS. 2023.
12. Interventions for Necrotizing Soft Tissue Infections in Adults. — Hua C, Bosc R, Sbidian E, et al. The Cochrane Database of Systematic Reviews. 2018.